[go: up one dir, main page]

DE60133600D1 - C7-carbamoyloxysubstituierte taxane als antitumormittel - Google Patents

C7-carbamoyloxysubstituierte taxane als antitumormittel

Info

Publication number
DE60133600D1
DE60133600D1 DE60133600T DE60133600T DE60133600D1 DE 60133600 D1 DE60133600 D1 DE 60133600D1 DE 60133600 T DE60133600 T DE 60133600T DE 60133600 T DE60133600 T DE 60133600T DE 60133600 D1 DE60133600 D1 DE 60133600D1
Authority
DE
Germany
Prior art keywords
carbamoyloxy
taxanese
antitum
substituted
substituent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60133600T
Other languages
English (en)
Other versions
DE60133600T2 (de
Inventor
Robert Holton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Florida State University Research Foundation Inc
Original Assignee
Florida State University Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Florida State University Research Foundation Inc filed Critical Florida State University Research Foundation Inc
Publication of DE60133600D1 publication Critical patent/DE60133600D1/de
Application granted granted Critical
Publication of DE60133600T2 publication Critical patent/DE60133600T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
DE60133600T 2000-02-02 2001-02-02 C7-carbamoyloxysubstituierte taxane als antitumormittel Expired - Fee Related DE60133600T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17967000P 2000-02-02 2000-02-02
US179670P 2000-02-02
PCT/US2001/003592 WO2001057028A1 (en) 2000-02-02 2001-02-02 C7 carbamoyloxy substituted taxanes as antitumor agents

Publications (2)

Publication Number Publication Date
DE60133600D1 true DE60133600D1 (de) 2008-05-29
DE60133600T2 DE60133600T2 (de) 2009-06-10

Family

ID=22657498

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60133600T Expired - Fee Related DE60133600T2 (de) 2000-02-02 2001-02-02 C7-carbamoyloxysubstituierte taxane als antitumormittel

Country Status (23)

Country Link
US (3) US6359154B2 (de)
EP (1) EP1165549B1 (de)
JP (1) JP2003522168A (de)
KR (1) KR20020002417A (de)
CN (1) CN1362956A (de)
AT (1) ATE392422T1 (de)
AU (1) AU778991B2 (de)
BR (1) BR0104355A (de)
CA (1) CA2368510A1 (de)
CZ (1) CZ20013521A3 (de)
DE (1) DE60133600T2 (de)
DK (1) DK1165549T3 (de)
ES (1) ES2305056T3 (de)
HK (1) HK1047937A1 (de)
HU (1) HUP0200752A3 (de)
IL (1) IL145643A0 (de)
MX (1) MXPA01009923A (de)
NO (1) NO20014757L (de)
NZ (1) NZ514410A (de)
PL (1) PL350024A1 (de)
PT (1) PT1165549E (de)
WO (1) WO2001057028A1 (de)
ZA (1) ZA200108056B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0200752A3 (en) * 2000-02-02 2005-02-28 Univ Florida State Res Found C7 carbamoyloxy substituted taxanes as antitumor agents
JP2003521545A (ja) * 2000-02-02 2003-07-15 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド 改良された溶解性を有するタキサン製剤
US7390898B2 (en) 2002-08-02 2008-06-24 Immunogen Inc. Cytotoxic agents containing novel potent taxanes and their therapeutic use
JP2005539009A (ja) * 2002-08-02 2005-12-22 イミュノジェン・インコーポレーテッド 新規の効力のあるタキサンを含む細胞毒性物質、および、それらの治療用途
CN110227164B (zh) * 2018-03-06 2021-11-23 江苏吉贝尔药业股份有限公司 含酮羰基的疏水性抗肿瘤药物及其缀合物、含有缀合物的纳米制剂及其制备方法及应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960790A (en) 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
US5175315A (en) 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
FR2679230B1 (fr) 1991-07-16 1993-11-19 Rhone Poulenc Rorer Sa Nouveaux derives d'analogues du taxol, leur preparation et les compositions qui les contiennent.
US5721268A (en) 1991-09-23 1998-02-24 Florida State University C7 taxane derivatives and pharmaceutical compositions containing them
US5350866A (en) 1991-09-23 1994-09-27 Bristol-Myers Squibb Company 10-desacetoxytaxol derivatives
US5283253A (en) 1991-09-23 1994-02-01 Florida State University Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
US5227400A (en) 1991-09-23 1993-07-13 Florida State University Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
US5430160A (en) 1991-09-23 1995-07-04 Florida State University Preparation of substituted isoserine esters using β-lactams and metal or ammonium alkoxides
US5714513A (en) 1991-09-23 1998-02-03 Florida State University C10 taxane derivatives and pharmaceutical compositions
US5243045A (en) 1991-09-23 1993-09-07 Florida State University Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
ATE195973T1 (de) 1992-01-15 2000-09-15 Squibb & Sons Inc Enzymatische verfahren zur resolution von enantiomeren-mischungen nützlich wie zwischenprodukte zur herstellung von taxanen
US5272171A (en) 1992-02-13 1993-12-21 Bristol-Myers Squibb Company Phosphonooxy and carbonate derivatives of taxol
US5614549A (en) * 1992-08-21 1997-03-25 Enzon, Inc. High molecular weight polymer-based prodrugs
CA2109861C (en) 1992-12-04 1999-03-16 Shu-Hui Chen 6,7-modified paclitaxels
CA2155304C (en) * 1993-02-05 2010-07-20 Charles Swindell Syntheses of paclitaxel, analogs and intermediates with variable a-ring side chains
IL109926A (en) 1993-06-15 2000-02-29 Bristol Myers Squibb Co Methods for the preparation of taxanes and microorganisms and enzymes utilized therein
TW397866B (en) 1993-07-14 2000-07-11 Bristol Myers Squibb Co Enzymatic processes for the resolution of enantiomeric mixtures of compounds useful as intermediates in the preparation of taxanes
US6100411A (en) 1994-10-28 2000-08-08 The Research Foundation Of State University Of New York Taxoid anti-tumor agents and pharmaceutical compositions thereof
WO1996013495A1 (en) 1994-10-28 1996-05-09 The Research Foundation Of State University Of New York Taxoid derivatives, their preparation and their use as antitumor agents
US5780653A (en) 1995-06-07 1998-07-14 Vivorx Pharmaceuticals, Inc. Nitrophenyl, 10-deacetylated substituted taxol derivatives as dual functional cytotoxic/radiosensitizers
CA2231837A1 (en) 1995-09-13 1997-03-20 Florida State University Radiosensitizing taxanes and their pharmaceutical preparations
US6545168B1 (en) 1996-05-06 2003-04-08 Florida State University 1-deoxy baccatin III, 1-deoxy taxol and 1-deoxy taxol analogs and method for the preparation thereof
US5811452A (en) 1997-01-08 1998-09-22 The Research Foundation Of State University Of New York Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof
US5912264A (en) 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
US7288665B1 (en) 1997-08-18 2007-10-30 Florida State University Process for selective derivatization of taxanes
HUP0200752A3 (en) * 2000-02-02 2005-02-28 Univ Florida State Res Found C7 carbamoyloxy substituted taxanes as antitumor agents

Also Published As

Publication number Publication date
PT1165549E (pt) 2008-06-20
JP2003522168A (ja) 2003-07-22
NO20014757D0 (no) 2001-10-01
EP1165549B1 (de) 2008-04-16
DK1165549T3 (da) 2008-08-11
HUP0200752A2 (en) 2002-10-28
US6359154B2 (en) 2002-03-19
BR0104355A (pt) 2002-01-02
ZA200108056B (en) 2003-12-01
EP1165549A1 (de) 2002-01-02
US20050020635A1 (en) 2005-01-27
MXPA01009923A (es) 2003-08-01
AU3330201A (en) 2001-08-14
NZ514410A (en) 2005-01-28
US20030060638A1 (en) 2003-03-27
HUP0200752A3 (en) 2005-02-28
US6750245B2 (en) 2004-06-15
NO20014757L (no) 2001-11-29
WO2001057028A1 (en) 2001-08-09
DE60133600T2 (de) 2009-06-10
ATE392422T1 (de) 2008-05-15
HK1047937A1 (zh) 2003-03-14
ES2305056T3 (es) 2008-11-01
CZ20013521A3 (cs) 2002-03-13
PL350024A1 (en) 2002-10-21
US20010051640A1 (en) 2001-12-13
IL145643A0 (en) 2002-06-30
KR20020002417A (ko) 2002-01-09
CA2368510A1 (en) 2001-08-09
AU778991B2 (en) 2004-12-23
CN1362956A (zh) 2002-08-07

Similar Documents

Publication Publication Date Title
ATE381328T1 (de) Heterosubstituierte taxan-c10-acetate als antitumormittel
BG105967A (en) C(7) ester substituted taxanes and their use as antitumor agents
DOP2001000151A (es) Derivados de imidazopirimidina y derivados de triazolopimidina.
NO20034660D0 (no) Spiropyrazolforbindelser
NO20014758L (no) C(7)-heterosubstituerte acetattaxaner som antitumormidler
BG105964A (en) C(10) carbonate substituted taxanes and their use as antitumor agents
DE60133600D1 (de) C7-carbamoyloxysubstituierte taxane als antitumormittel
DE60134814D1 (de) C10-carbamoyloxysubstituierte taxane als antitumormittel
DE60138853D1 (de) C10-taxanester als antitumormittel
BG105966A (en) C7 carbonate substituted taxanes and their application as antitumor agents
SG125888A1 (en) C10 carbonate substituted taxanes
SG125889A1 (en) C7 ester subsituted taxanes

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: HOLTON, ROBERT A., TALLAHASSEE, FLA., US

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee